Mapatumumab (Anti-TNFRSF10A / TRAILR1 / CD261)
A2332
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameMapatumumab (Anti-TNFRSF10A / TRAILR1 / CD261)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionMapatumumab (Anti-TNFRSF10A / TRAILR1 / CD261) is a fully human IgG1 agonistic monoclonal antibody that targets tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) with apoptosis promoting and potential antitumor activities. MW : 145.5 KD.
- Storage Instruction-20°C
- UNSPSC12352203